Rise and shine, everyone, another busy day is on the way. We can tell because the short person scurried for the ride to the local schoolhouse and the official mascots are enjoying a warm and shiny sun that makes it easier to sniff edibles hidden on the official Pharmalot grounds. As for us, yes, we are quaffing cups of stimulation as we begin a fresh round of meetings and storytelling. On that note, we have a menu of tidbits for you to peruse. Hope you accomplish much today and, as always, do keep in touch …

AstraZeneca (AZN) and Shire (SHPG) made $27 million in “secret” payments to health care professionals and organizations across Europe to boost medicines, The Times of London reports. The money covered consultancy fees and “related expenses,” and travel and accommodation for events organized or sponsored by the companies. The anonymous payments were made despite a European self-regulatory code of conduct encouraging drug makers to renegotiate contracts with professionals, such as doctors, and health organizations in order to include consent to disclose details.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy